Showing results (21-30 of 34) with videos related to
Sort By:
Pageof 4
Anticancer Research|September 30, 2024
Anticancer Effects of BAF312 (Siponimod) in Epithelial Ovarian CancerHeeeun Ha, Ji-Yoon Ryu, Suin Yoon, et al.Gynecologic Oncology|May 11, 2021
Establishment and preclinical application of a patient-derived xenograft model for uterine cancerSoo Young Jeong, Young-Jae Cho, Ji-Yoon Ryu, et al.Gynecologic Oncology|June 27, 2024
Anti-cancer effects of benzimidazole derivative BNZ-111 on paclitaxel-resistant ovarian cancerByumseok Koh, Ji-Yoon Ryu, Joseph J Noh, et al.Gynecologic Oncology|March 20, 2022
Combination effect of poly (ADP-ribose) polymerase inhibitor and DNA demethylating agents for treatment of epithelial ovarian cancerJung-In Shim, Ji-Yoon Ryu, Soo Young Jeong, et al.Cancer Cell International|January 25, 2024
The anti-tumor effects of AZD4547 on ovarian cancer cells: differential responses based on c-Met and FGF19/FGFR4 expressionYoo-Young Lee, Ji-Yoon Ryu, Young-Jae Cho, et al.Journal of Hypertension|November 2, 2022
Hydroxychloroquine reduces hypertension and soluble fms-like kinase-1 in a Nω-nitro-l-arginine methyl ester-induced preeclampsia rat modelMinji Choi, Jae Ryoung Hwang, Ji-Hee Sung, et al.Journal of Clinical Medicine|April 23, 2020
Identification of Candidate Genes Associated with Susceptibility to Ovarian Clear Cell Adenocarcinoma Using <i>cis</i>-eQTL AnalysisJihye Kim, Joon-Yong Chung, Jae Ryoung Hwang, et al.Biochemical and Biophysical Research Communications|December 9, 2009
Intermolecular cross-talk between NTR1 and NTR2 neurotensin receptor promotes intracellular sequestration and functional inhibition of NTR1 receptorsJae Ryoung Hwang, Min Woo Baek, Jeonggu Sim, et al.Pharmaceutics|October 22, 2020
Anti-Cancer Activity of As<sub>4</sub>O<sub>6</sub> and its Efficacy in a Series of Patient-Derived Xenografts for Human Cervical CancerJoseph J Noh, Myeong-Seon Kim, Young-Jae Cho, et al.Pharmaceutics|May 4, 2026
Time-Resolved Transcriptomic Profiling of Surgical Wounds Identifies Stage-Specific Therapeutic Targets for Residual Ovarian CancerSeongyun Lim, Young-Jae Cho, Myeong-Seon Kim, et al.Pageof 4